Twosmalltrialspublished in 2000 and 2004 by MatthewMuldoon, a clinicalpharmacologist at theUniversity of Pittsburgh, seem to suggest a link between statins and cognitiveproblems.
For instance, Raymond Woosley , vice president of health research at the University of Arizona and a noted pharmacologist, has said that the antihistamine Chlor-Trimetron was originally approved not based on a clinical trial, but by a survey of doctors.